GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (FRA:LSRM) » Definitions » General and Admin. Expense

CEL-SCI (FRA:LSRM) General and Admin. Expense : €8.53 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is CEL-SCI General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. CEL-SCI's General and Admin. Expense for the three months ended in Mar. 2024 was €2.25 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €8.53 Mil.

CEL-SCI General and Admin. Expense Historical Data

The historical data trend for CEL-SCI's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CEL-SCI General and Admin. Expense Chart

CEL-SCI Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.26 9.94 11.12 10.81 8.44

CEL-SCI Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.96 2.27 2.06 1.96 2.25

CEL-SCI General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CEL-SCI General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of CEL-SCI's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CEL-SCI (FRA:LSRM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (FRA:LSRM) » Definitions » General and Admin. Expense
Comparable Companies
TLSA MRNS IFRX TPST SPRO AFMD CGTX CMRX BTAI PASG OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
CVM:USA
Address
8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
Website
https://www.cel-sci.com
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEL-SCI (FRA:LSRM) Headlines

No Headlines